The Effects of Unfiltered (Turkish) Coffee Consumption on Cardiovascular Risk Parameters

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03495336
• Date of registration: 17/03/2018
• Prospective Registration: No
• Primary sponsor: Eastern Mediterranean University
• Public title: The Effects of Unfiltered (Turkish) Coffee Consumption on Cardiovascular Risk Parameters
• Scientific title: A 4-week Consumption of Light or Dark Roast Unfiltered (Turkish) Coffee Affects Cardiovascular Risk Parameters of Homocysteine and Cholesterol Concentrations in Healthy Subjects: A Randomized Crossover Clinical Trial
• Date of first enrolment: March 22, 2017
• Target sample size: 28
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03495336
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Cyprus

Contacts

• Name: Tanju Besler, Prof.
• Affiliation: Eastern Mediterranean University

Key inclusion & exclusion criteria

Inclusion Criteria:

- Regular Turkish coffee consumer = 1 cups/day

- Body mass index (BMI) 18.5-24.9 kg/m2 )

- Non-smoker or former smoker (more than a year)

- Willingness to abstain from coffee drinking

- Willingness to consume = 3 cups/day of Turkish coffee

Exclusion Criteria:

- Acute or chronic diseases

- Severe illness with in-patient treatment during last 3 months

- Use of regular medication or any supplements

- Weight reduction ?2 kg/week during the last month

- Pregnancy or breastfeeding

- Regular strong physical activity with =1h/day

- High alcohol intake a weekly intake of ?7 units for women and ?14units for men

- Excess consumption of total fat ?35% of daily calories

- Consumption of saturated fatty acid ?10% of daily calories

- Cholesterol intake ?300mg/day



Age minimum: 20 Years
Age maximum: 35 Years
Gender: All

Health Condition(s) or Problem(s) studied

Cardiovascular Diseases

Intervention(s)

Other: LR Coffee consumption

Other: DR Coffee consumption

Other: coffee abstention phase

Primary Outcome(s)

Comparing the serum lipid levels of all interventions [Time Frame: 12 weeks]

Secondary Outcome(s)

Comparing the waist circumference (cm) of all interventions [Time Frame: 12 weeks]

Comparing the 3-day food diaries (1 weekend day and 2 weekdays) taken during each intervention [Time Frame: 12 weeks]

Comparing the blood pressure (BP) (Systolic and Diastolic blood pressure (mmHg)) of all interventions [Time Frame: 12 weeks]

Comparing the weight (kg) of all interventions [Time Frame: 12 weeks]

Comparing the body fat percentage (%) of all interventions [Time Frame: 12 weeks]

Comparing the physical activity levels of each intervention [Time Frame: 12 weeks]

Comparing the Homocysteine levels of all interventions [Time Frame: 12 weeks]

Comparing the fasting blood glucose levels of all interventions [Time Frame: 12 weeks]

Comparing the serum Malondialdehyde levels of all interventions [Time Frame: 12 weeks]

Comparing the body mass index (BMI) of all interventions [Time Frame: 12 weeks]

Comparing the height (cm) of all interventions [Time Frame: 12 weeks]

Secondary ID(s)

EasternMedU

Source(s) of Monetary Support

Please refer to primary and secondary sponsors